A health ministry panel agreed Friday that doctors in Japan should be able to use a new domestically produced influenza drug to treat people who get infected with the deadly Ebola virus, although it has not yet been approved for such use.
Favipiravir, marketed as Avigan Tablet, has drawn renewed attention after a French nurse recovered from Ebola after taking it in conjunction with two other types of medicine made in the United States and Canada.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.